Germ Cell Cancer Clinical Trial
Official title:
A Pilot Study Measuring Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls
Cisplatin is one of the most common chemotherapy drugs used to treat many different cancers, including germ cell tumors (GCT). Cisplatin is very effective in treating GCT, but there are side effects. One of the possible long-term side effects of cisplatin is thought to be heart disease. The way that cisplatin causes heart disease is not well understood. One possibility is that cisplatin may damage the inside layer of blood vessels called the endothelium. The purpose of this study is to measure changes in the endothelium that happen when patients with GCT get cisplatin chemotherapy and to compare these changes with a group of patients not receiving chemotherapy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT00996710 -
Genomic Structural Variation in Cancer Susceptibility
|
||
| Completed |
NCT01242631 -
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
|
Phase 2 | |
| Completed |
NCT01851200 -
Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
|
Phase 2 | |
| Not yet recruiting |
NCT06275854 -
YASU Research Registry: For Young Adults With Cancer
|
||
| Recruiting |
NCT04897321 -
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
|
Phase 1 | |
| Completed |
NCT02303015 -
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
|
||
| Not yet recruiting |
NCT06329323 -
SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours
|